您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > R-7128
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
R-7128
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
R-7128图片
CAS NO:940908-79-2
规格:98%
分子量:399.41
包装与价格:
包装价格(元)
5mg电议
10mg电议
50mg电议

产品介绍
NS5B inhibitor
CAS:940908-79-2
分子式:C18H26FN3O6
分子量:399.41
纯度:98%
存储:Store at -20°C

Background:

R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.


Hepatitis C virus (HCV) is an enveloped (+)-single stranded RNA virus, and the viral RNA is replicated in host cell via HCV's RNA-dependent RNA polymerase, which is the cause of hepatitis C and some cancer lymphomas.


R-7128 is a nucleotide triphosphate analog which is the substrate for HCV polymerase NS5B. Incorporation of R-7128 into nascent HCV RNA strongly decreased the efficiency of RNA elongation by RNA polymerase NS5B, leading to the termination of the nascent RNA product. It has been shown that R-7128 is able to inhibit the RNA synthesis of HCV in vitro [1].


32 patient infected with HCV genotype-1 was treated with R-7128 for 14 days with 750-mg or 1500-mg administered once (QD) or twice daily (BID), and the HCV RNA level was frequently measured. Initial decline of HCV RNA was generally slower than treatment with interferon-alpha or protease inhibitors but 12 patients showed a novel pattern of HCV RNA kinetics that the effectiveness in inhibiting viral production gradually increased over time to reach its final value. The final value was high with BID dose (mean 750-mg and 1500-mg: 98.0% and 99.8%, P=0.018) and significantly higher than in patients treated QD (mean QD vs BID: 90% vs 99%, P<10^-7) [2].


参考文献:
[1] Ma H et al. , Characterization of the metabolic activation of Hepatitis C virus nucleoside inhibitor β-D-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) and identification of a novel active 5′-Triphosphate species. J Biol Chem. 2007, 282(41): 29812-20.
[2] Guedj J et al. , Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128). Hepatology. 2012, 55(4): 1030-1037.